857904-03-1 Usage
Description
12-Oxa-2,5,6,10-tetraazatetradecanoic acid, 3-(1,1-dimethylethyl)-8-hydroxy-13,13-dimethyl-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, methyl ester, (3S,8S,9S)is a complex organic compound that serves as an intermediate in the synthesis of Atazanavir-d9, a deuterated analog of Atazanavir. Atazanavir is an azapeptide HIV protease inhibitor derivative that has been investigated for its potential in treating human immunodeficiency virus (HIV) and for anticancer purposes.
Uses
Used in Pharmaceutical Industry:
12-Oxa-2,5,6,10-tetraazatetradecanoic acid, 3-(1,1-dimethylethyl)-8-hydroxy-13,13-dimethyl-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, methyl ester, (3S,8S,9S)is used as an intermediate in the synthesis of Atazanavir-d9 for its potential applications in treating human immunodeficiency virus (HIV) and for anticancer purposes. 12-Oxa-2,5,6,10-tetraazatetradecanoic acid, 3-(1,1-diMethylethyl)-8-hydroxy-13,13-diMethyl-4,11-dioxo-9-(phenylMethyl)-6-[[4-(2-pyridinyl)phenyl]Methyl]-, Methyl ester, (3S,8S,9S)plays a crucial role in the development of new therapeutic agents that can target and inhibit the replication of HIV and cancer cells, offering potential benefits in the treatment of these diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 857904-03-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,7,9,0 and 4 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 857904-03:
(8*8)+(7*5)+(6*7)+(5*9)+(4*0)+(3*4)+(2*0)+(1*3)=201
201 % 10 = 1
So 857904-03-1 is a valid CAS Registry Number.
857904-03-1Relevant articles and documents
NOVEL AZA-PEPTIDES CONTAINING 2,2-DISUBSTITUTED CYCLOBUTYL AND/OR SUBSTITUTED ALKOXY BENZYL DERIVATIVES AS ANTIVIRALS
-
, (2011/07/30)
The present invention relates to novel aza-peptides containing 2,2-disubstituted 5 cyclobutyl and/or substituted alkoxy benzyl derivatives of formula (I) and compositions for inhibiting Human Immunodeficiency Virus (HIV) and process for making the compounds.
HIV PROTEASE INHIBITING COMPOUNDS
-
Page/Page column 110, (2010/02/12)
A compound of the formula (I) is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.
A facile and efficient synthesis of d3-labelled Reyataz
Zhang, Huiping,Bonacorsi Jr., Samuel J.,Chen, Bang-Chi,Leith, Leslie W.,Rinehart, J. Kent,Balasubramanian, Balu,Barrish, Joel C.
, p. 1041 - 1047 (2007/10/03)
A facile and efficient synthesis of d3-labelled Reyataz is described. The key step of synthesis involved the coupling of N-(d 3-methoxycarbonyl)-L-tert-leucine 2b with an advanced chiral non-racemic building block 4. The latter was synthesized in 4 steps from the readily accessible hydrazine derivative 8. Copyright